Responses
Immune cell therapies and immune cell engineering
Original research
Nanopore sequencing as a scalable, cost-effective platform for analyzing polyclonal vector integration sites following clinical T cell therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.